Table 3.

Between-group comparison of CEC levels at different time-points.

Groups	Cases	Before modeling (1/0.9 μl)	After modeling (1/0.9 μl)	After 4 weeks of injection (1/0.9 μl)
Saline	8	5.15±0.14	9.92±0.75	9.90±0.77
pVAX1	8	5.14±0.13	9.95±0.74	9.94±0.73
pVAX1-ADM (low-dose)	8	5.13±0.15	9.91±0.77	8.42±0.54*
pVAX1-ADM (mid-dose)	8	5.11±0.14	9.94±0.72	6.85±0.45*,#
pVAX1-ADMg (high-dose)	8	5.15±0.15	9.98±0.75	5.95±0.37*,#,@

Comparison with the saline group and pVAX group,

^*P<0.05; comparison with the pVAX1-ADM low-dose group,

^#P<0.05; comparison with the pVAX1-ADM mid-dose group,

^@P<0.05.